News Sentiment

ACET sentiment intelligence

Adicet Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 46 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.83 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-1.9% over one week, +9.7% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Is Adicet Bio (ACET) stock outpacing its medical peers this year?

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -1.9% Price digesting
Trend fit Trend active 9.7% over four weeks
Fair value -52.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 34
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 9
TradingView 7
www.marketscreener.com 3
TradingKey 3
MSN 2
Quartr 2
Benzinga 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 14
Analyst action 5
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 46
TradingView Direct company coverage

Price to earnings forward of Adicet Bio, Inc. – NASDAQ:ACET

This page provides financial information for Adicet Bio, Inc. (NASDAQ: ACET), specifically focusing on its forward price-to-earnings ratio. The content appears to be from TradingView, offering a snapshot of financial data and market status for the company.

Tone
Neutral 50/100
Event
Earnings
Published
11 Jul 2026 09:39
Source
TradingView
Quartr Direct company coverage

Adicet Bio (ACET) Proxy filing Summary

This article summarizes Adicet Bio's proxy filing, detailing the annual meeting scheduled for June 17, 2026. Key items for shareholder voting include the election of three Class II directors, an advisory vote on executive compensation, and the ratification of KPMG LLP as the inde

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 17:12
Source
Quartr
www.marketscreener.com Direct company coverage

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Index

Adicet Bio, Inc. (NasdaqCM: ACET), a clinical-stage biotechnology company, has been added to the Russell 3000E Index. The company focuses on developing off-the-shelf gamma delta T cells engineered with chimeric antigen receptors (CARs) for autoimmune diseases and solid tumors. It

Tone
Positive 71/100
Event
Market update
Published
29 Jun 2026 21:09
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Value Benchmark

Adicet Bio, Inc. (NasdaqCM: ACET) has been added to the Russell 3000E Value Benchmark. This news follows earlier announcements that the company was also added to the Russell Microcap Value Benchmark Index and the Russell Microcap Index on June 29, 2026, and the Russell 3000E Inde

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 20:41
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index

Adicet Bio, Inc. (NasdaqCM: ACET) has been added to the Russell Microcap Value Benchmark Index. The clinical-stage biotechnology company focuses on developing off-the-shelf gamma delta T cell therapies, with its lead product candidate, ADI-001, targeting autoimmune diseases. This

Tone
Positive 70/100
Event
Market update
Published
29 Jun 2026 13:40
Source
www.marketscreener.com
TradingView Direct company coverage

Adicet Bio Inc Actuals & Estimates (MUN:1IJ)

This article provides an overview of Adicet Bio Inc (MUN:1IJ) stock, including financial actuals and analyst estimates. It covers the company's past performance, future price forecasts, earnings reports, revenue, net income, and employee count. The article also provides details o

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 19:09
Source
TradingView
TradingView Direct company coverage

ACET Forecast — Price Target — Prediction for 2027

The article provides a forecast for Adicet Bio, Inc. (ACET) stock, including analyst price targets, historical performance, and current financial metrics. Analysts have given ACET a max estimate of $100.00 and a min estimate of $18.00. The company's recent stock performance and u

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 19:09
Source
TradingView
TradingView Direct company coverage

1IJ Forecast — Price Target — Prediction for 2027

This article provides a forecast for Adicet Bio Inc (1IJ) stock, including analyst price targets and future predictions. It details the company's past financial performance, upcoming earnings dates, and current employee count. The article also addresses frequently asked questions

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 18:10
Source
TradingView
TradingView Direct company coverage

Adicet Bio Inc Actuals & Estimates (TRADEGATE:1IJ)

This article provides financial actuals and estimates for Adicet Bio Inc (TRADEGATE:1IJ), including income statements, balance sheets, cash flow data, and valuations. It also offers analyst forecasts, historical price data, upcoming earnings reports, and other key financial metri

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:10
Source
TradingView
Benzinga Direct company coverage

12 Health Care Stocks Moving In Thursday's Pre-Market Session

This article lists 12 healthcare stocks experiencing significant movement in pre-market trading on Thursday. It details both gainers like Adicet Bio, Bio-Techne, and TELA Bio, noting their percentage increase and market values. Conversely, it also highlights decliners such as ARS

Tone
Positive 76/100
Event
Market update
Published
25 Jun 2026 11:40
Source
Benzinga
Stock Titan Direct company coverage

Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike

Adicet Bio director Andrew Sinclair was granted 4,200 stock options at an exercise price of $8.10 per share as part of his board compensation. These options, which expire on June 20, 2036, will vest fully on the earlier of the first anniversary of the grant date or the next annua

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 18:09
Source
Stock Titan
Stock Titan Direct company coverage

Adicet Bio (ACET) CEO Chen Schor receives 55,000 stock options at $8.10

Chen Schor, President & CEO of Adicet Bio (ACET), has been granted a new stock option award for 55,000 shares. These options have an exercise price of $8.10 per share and will vest monthly over four years, with potential for accelerated vesting based on specific performance miles

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 23:09
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 Adicet Bio Inc For: 23 June By Investing.com

This article from Investing.com reports the filing of a Form 4 for Adicet Bio Inc. on June 23. Form 4 filings are legally required documents submitted to the SEC by company insiders, like officers and directors, to report changes in their ownership of the company's restricted sto

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 23:09
Source
Investing.com Canada
Stock Titan Direct company coverage

Adicet Bio (ACET) grants CSO Blake Aftab 55,000 stock options

Adicet Bio, Inc. has granted its Chief Scientific Officer, Blake Aftab, 55,000 stock options with an exercise price of $8.10 per share, expiring on June 18, 2036. These options are compensation-related and will vest over 48 monthly anniversaries of the grant date, with potential

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Adicet Bio (ACET) director receives stock options for 4,200 shares at $8.10

Adicet Bio director Michael Grissinger was granted stock options for 4,200 shares of common stock at an exercise price of $8.10 per share, expiring on June 20, 2036. This compensation-related grant will vest in full on the earlier of the first anniversary of the grant date or the

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Director Katie Peng receives 4,200 Adicet Bio (ACET) stock options at $8.10

Adicet Bio director Katie Peng was granted 4,200 stock options with an exercise price of $8.10 per share, set to expire on June 20, 2036. The options will vest fully on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting, provided her c

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Adicet Bio (ACET) investors back board nominees, pay and KPMG at 2026 meeting

Adicet Bio, Inc. (ACET) held its 2026 Annual Meeting of Stockholders, where shareholders approved the election of three Class II directors, Jeffrey Chodakewitz, Steve Dubin, and Michael Grissinger, to three-year terms. They also passed a non-binding advisory vote on the compensat

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 19:40
Source
Stock Titan
TradingKey Direct company coverage

Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Adicet Bio Inc's (ACET) dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years but lists several past merger-related stock splits. The company's current market capitaliza

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Jun 2026 06:39
Source
TradingKey
TradingKey Direct company coverage

Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Adicet Bio Inc (ACET), indicating a current earnings forecast score of 9.00 and an average price target of $8.00 based on 6 analysts. Most analysts recommend a "STRONG BUY" for ACET stock, with a projected upside space of over 348%. T

Tone
Positive 70/100
Event
Earnings
Published
18 Jun 2026 05:39
Source
TradingKey
TradingKey Direct company coverage

Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Adicet Bio Inc (ACET), noting its current valuation score of 8.21, ranking 161 out of 388 in the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -0.58, which is significantly below its recent high

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 02:38
Source
TradingKey
Quartr Direct company coverage

Adicet Bio (ACET) Jefferies Global Healthcare Conference 2026 Summary

The article summarizes Adicet Bio's presentation at the Jefferies Global Healthcare Conference 2026, focusing on their gamma delta T cell platform and clinical progress. Key updates include their lead candidate, prula-cel (ADI-001), being evaluated for several autoimmune indicati

Tone
Positive 66/100
Event
Market update
Published
07 Jun 2026 15:41
Source
Quartr